Ovarian Germ Cell Tumor
📧 Sign up to get email alerts when something new happens for Ovarian Germ Cell Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors [Phase 3]
A Phase 3 clinical trial update on active surveillance followed by BEP-like regimens (bleomycin, etoposide, with carboplatin or cisplatin) i…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors [Phase 1]
Phase 1 safety and tolerability study of XmAb541 in advanced solid tumors is currently recruiting, investigating ovarian cancer, endometrial…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Phase II Trial of Cabozantinib With Patients With Refractory GCTs [Phase 2]
Update on a Phase II trial of cabozantinib in patients with refractory germ cell tumors.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy [NA]
This clinical trial update reports an ongoing study examining chronic fatigue, quality of life, and late effects of chemotherapy in women wi…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT [Phase 2]
A Phase 2 trial is evaluating maintenance oral etoposide after high-dose chemotherapy for germ cell tumors. The study compares maintenance t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor [Phase 1]
Phase 1 trial evaluating a conditioning regimen of busulfan, melphalan, and topotecan hydrochloride followed by stem cell transplantation in…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors [Phase 3]
Phase 3 clinical trial evaluating TC or BEP chemotherapy in patients with malignant ovarian germ cell tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2021-03-11Clinical Trial Update: Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer [Phase 2]
Phase II trial of the CDK inhibitor PD 0332991 (palbociclib) in various adult solid tumors including colon and breast cancers has completed …
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of everolimus and letrozole in patients with recurrent hormone receptor-positive ovarian…
-
CLINICAL_TRIALS withdrawal · 2019-02-20Clinical Trial Update: Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating metformin hydrochloride with carboplatin and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer [Phase 1]
A Phase I trial evaluating stereotactic body radiotherapy for metastatic or recurrent platinum-resistant ovarian cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors [Phase 2]
A Phase 2 clinical trial evaluated alvocidib plus oxaliplatin with or without fluorouracil and leucovorin calcium in relapsed or refractory …
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin [Phase 1, Phase 2]
Phase 1/2 trial evaluating paclitaxel, ifosfamide, and carboplatin followed by autologous stem cell transplant in patients with cisplatin-re…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer [NA]
This completed clinical trial from Ohio State University Comprehensive Cancer Center evaluated whether stress-reduction interventions can im…
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer [Phase 1]
Phase 1 trial evaluating the combination of carboplatin, gemcitabine hydrochloride, and stereotactic body radiation therapy in gynecologic c…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors [Phase 2]
Phase 2 trial of palifosfamide for recurrent germ cell tumors was terminated; results were posted in 2015.
-
CLINICAL_TRIALS withdrawal · 2015-06-18Clinical Trial Update: Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study
A 27-year population-based study analyzes trends in incidence and survival for ovarian germ cell tumors. The associated clinical trial NCT00…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy for young patients with recurrent or resistant malignant germ cell tumors; study …
-
CLINICAL_TRIALS withdrawal · 2014-12-23Clinical Trial Update: Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer [NA]
The clinical trial NCT01927393 evaluating palliative care to improve quality of life and symptoms in stage III-IV pancreatic or ovarian canc…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) [NA]
Update on the PLCO ovarian cancer screening trial in older adults; results were posted in 2014 and the study remains active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine [Phase 1]
Phase 1 study evaluating conditioning with cyclophosphamide or denileukin diftitox followed by expansion of the patient’s own T cells for HE…
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating a combination of temsirolimus, carboplatin, and paclitaxel in adults with advanced solid tumors, including ovarian …
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 update on a veliparib, oxaliplatin, and capecitabine combination in patients with advanced solid tumors. The study, including pancre…
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies [Phase 2]
This report covers results from a Phase 2 trial using the CyberKnife stereotactic radiosurgery system to treat advanced or recurrent gynecol…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors [NA]
A completed clinical trial evaluated pelvic floor muscle training for urinary incontinence in survivors of gynecologic cancers.